EPISODIC ATAXIA TYPE 2

Clinical trials for EPISODIC ATAXIA TYPE 2 explained in plain language.

Never miss a new study

Get alerted when new EPISODIC ATAXIA TYPE 2 trials appear

Sign up with your email to follow new studies for EPISODIC ATAXIA TYPE 2, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Hope for rare brain disease: Final-Stage trial tests promising pill

Disease control Not yet recruiting

This study is testing if a medication called N-Acetyl-L-Leucine can help control symptoms and improve daily life for people with rare, inherited disorders caused by a faulty CACNA1A gene. These disorders affect coordination, balance, and speech. In this final-stage trial, 60 part…

Matched conditions: EPISODIC ATAXIA TYPE 2

Phase: PHASE3 • Sponsor: IntraBio Inc • Aim: Disease control

Last updated Mar 27, 2026 12:40 UTC

EPISODIC ATAXIA TYPE 2

Get alerted when new EPISODIC ATAXIA TYPE 2 trials appear

Hope for rare brain disease: Final-Stage trial tests promising pill